Lifen Datalab
HARPE register
Launched in June 2024, the HARPE project aims to establish a national registry dedicated to hereditary angioedema. This registry, presented in the form of an interactive platform, has a dual objective: firstly, to improve patient care and coordination; secondly, to facilitate and accelerate research.
CONTACT US

Project background & objectives

Hereditary angioedema (HAE) is a genetic disorder characterized by transient, recurrent subcutaneous and/or submucosal edema. In France, around 1,500 people suffer from this condition. Management of hereditary angioedema requires regular follow-up by one of the 18 centers of reference for hereditary kinin angioedema (CREAK).

The HARPE (Hereditary Angioedema Registry and Patient Evaluation) project, led by Grenoble Alpes University Hospital as CREAK hospital coordinator, aims to create a single national registry dedicated to patients diagnosed with hereditary angioedema. The aim of this project is toincrease medical knowledge and improve the quality of care for patients suffering from this disease.

Institutional support has been provided by BioCryst France, a biotechnology laboratory specializing in rare diseases. Additional funding is being sought through calls for projects and from other manufacturers, with the support of Carely, a consulting firm specializing in innovative healthcare projects.

1500
AOH PATIENTS IN FRANCE
+18
AOH REFERENCE CENTER IN FRANCE
90
VARIABLES

The patient's voice

The Patients en Réseau association brings together patients and relatives affected by cancer, and was created on the basis of their experiences. Meet the Patients en Réseau association
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Participating centers
No items found.
No items found.

Inclusion criteria & study variables

The HARPE project targets all patients diagnosed with hereditary angioedema (HAE). The registry is made up of numerous variables covering the following areas:

  • Genre,
  • Date of birth,
  • vital status,
  • DATE OF DEATH,
  • Cause of death etc...
  • SMOKING STATUS,
  • cannabis consumption,
  • vital status
    • DIAGNOSIS DATE,
    • METASTATIC AT DIAGNOSIS,
    • TNM STATUS AT DIAGNOSIS,
    • HISTOLOGICAL SUBTYPE,
    • metastatic sites,
    • MUTATIONS etc...
    • TYPE OF TREATMENT,
    • drugs used,
    • BETTER RESPONSE TO TREATMENT,
    • PROGRESSION ETC...

    Scientific Committee

    No items found.
    No items found.

    Key dates

    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.

    Posters & Publications

    No items found.
    No items found.

    Research projects

    Here you will find all the study projects using the cohort. These projects comply with the regulatory framework and have been approved in advance by the cohort's scientific committee:

    Patients

    Why take part in the project?

    Some of your medical and administrative data is collected when you are treated in a healthcare facility. This data is useful for the advancement of research.

    This research, conducted in the public interest, aims to develop knowledge in order to develop new treatments or improve the overall management of patients suffering from the same disease as you. If you agree to your data being used for this study, you will not have to make any additional visits or undergo any additional examinations.

    Only information already in your medical file will be collected. No directly identifying data (surname, first name or contact details) will be included in the cohorts.  

    If you wish to object to the processing of your data, you may exercise your rights by informing :

    If you wish to object to the processing of your data, you may exercise your rights by informing :

    • your hospital doctor treating you for angioedema or ;
    • Lifen's Data Protection Officer at the following address: dpo@lifen.fr ;
    • or by completing the opposition form.
    Would you like to find out more?
    Fill in your details, and our teams will get back to you as soon as possible.
    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.